Correlation of Urinary and Serum Hormone Levels in Natural Cycle Frozen Embryo Transfer Cycles
Launched by OTTAWA FERTILITY CENTRE · May 6, 2024
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to monitor hormone levels for women who are preparing for a frozen embryo transfer (FET) as part of their fertility treatment. Specifically, researchers want to see if measuring certain hormones in urine, using a simple at-home device, can accurately indicate important hormone changes that are typically checked through blood tests at a clinic. The goal is to find out if this home monitoring could help women time their FET more conveniently, potentially reducing the number of clinic visits they need.
To participate in this study, women who are scheduled for a natural cycle frozen embryo transfer and are willing to join the research may be eligible. There are no specific exclusions based on health conditions, so most women in this situation could take part. If successful, this trial could change how fertility care is delivered, making it easier and less invasive for patients while still ensuring effective treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All patients scheduled for a natural cycle frozen embryo transfer
- • Agree to participate in the research study
- Exclusion Criteria:
- • There are no exclusions
About Ottawa Fertility Centre
The Ottawa Fertility Centre (OFC) is a leading reproductive health clinic dedicated to providing comprehensive fertility services and innovative treatment options. With a commitment to advancing reproductive medicine, OFC conducts clinical trials aimed at improving patient outcomes and exploring novel approaches to fertility challenges. The center is staffed by a multidisciplinary team of highly trained specialists who leverage state-of-the-art technology and evidence-based practices to deliver personalized care tailored to each patient's unique needs. Through its research initiatives, the Ottawa Fertility Centre strives to contribute to the global understanding of fertility and enhance the quality of care for individuals and couples facing reproductive challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Jenna Gale, MD
Principal Investigator
Ottawa Fertility Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported